Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SRF
|
ENSG00000112658.6 | serum response factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SRF | hg19_v2_chr6_+_43139037_43139094 | 0.04 | 8.4e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_+_151561506 | 12.98 |
ENST00000253332.1
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
chr6_+_151561085 | 9.25 |
ENST00000402676.2
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
chr5_+_137801160 | 8.88 |
ENST00000239938.4
|
EGR1
|
early growth response 1 |
chr11_-_65667997 | 8.78 |
ENST00000312562.2
ENST00000534222.1 |
FOSL1
|
FOS-like antigen 1 |
chr11_-_65667884 | 7.43 |
ENST00000448083.2
ENST00000531493.1 ENST00000532401.1 |
FOSL1
|
FOS-like antigen 1 |
chr14_-_94443105 | 7.11 |
ENST00000555019.1
|
ASB2
|
ankyrin repeat and SOCS box containing 2 |
chr19_-_15344243 | 6.49 |
ENST00000602233.1
|
EPHX3
|
epoxide hydrolase 3 |
chr14_+_75745477 | 6.45 |
ENST00000303562.4
ENST00000554617.1 ENST00000554212.1 ENST00000535987.1 ENST00000555242.1 |
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
chr12_+_4382917 | 6.44 |
ENST00000261254.3
|
CCND2
|
cyclin D2 |
chr2_-_161056762 | 5.77 |
ENST00000428609.2
ENST00000409967.2 |
ITGB6
|
integrin, beta 6 |
chr19_-_15343773 | 5.76 |
ENST00000435261.1
ENST00000594042.1 |
EPHX3
|
epoxide hydrolase 3 |
chr2_+_74120094 | 5.74 |
ENST00000409731.3
ENST00000345517.3 ENST00000409918.1 ENST00000442912.1 ENST00000409624.1 |
ACTG2
|
actin, gamma 2, smooth muscle, enteric |
chr19_+_54372639 | 5.60 |
ENST00000391769.2
|
MYADM
|
myeloid-associated differentiation marker |
chrX_-_153602991 | 5.32 |
ENST00000369850.3
ENST00000422373.1 |
FLNA
|
filamin A, alpha |
chr19_+_16178317 | 4.92 |
ENST00000344824.6
ENST00000538887.1 |
TPM4
|
tropomyosin 4 |
chr2_-_161056802 | 4.90 |
ENST00000283249.2
ENST00000409872.1 |
ITGB6
|
integrin, beta 6 |
chr10_+_112257596 | 4.68 |
ENST00000369583.3
|
DUSP5
|
dual specificity phosphatase 5 |
chr5_+_150404904 | 4.17 |
ENST00000521632.1
|
GPX3
|
glutathione peroxidase 3 (plasma) |
chr10_-_90712520 | 3.97 |
ENST00000224784.6
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta |
chr7_+_143078652 | 3.82 |
ENST00000354434.4
ENST00000449423.2 |
ZYX
|
zyxin |
chr1_+_167599330 | 3.72 |
ENST00000367854.3
ENST00000361496.3 |
RCSD1
|
RCSD domain containing 1 |
chr12_+_75874460 | 3.71 |
ENST00000266659.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr10_-_17659234 | 3.69 |
ENST00000466335.1
|
PTPLA
|
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
chr12_+_75874580 | 3.50 |
ENST00000456650.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr8_-_143696833 | 3.49 |
ENST00000356613.2
|
ARC
|
activity-regulated cytoskeleton-associated protein |
chr2_-_208031943 | 3.40 |
ENST00000421199.1
ENST00000457962.1 |
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
chr11_-_65626753 | 3.25 |
ENST00000526975.1
ENST00000531413.1 |
CFL1
|
cofilin 1 (non-muscle) |
chr9_+_131644781 | 3.24 |
ENST00000259324.5
|
LRRC8A
|
leucine rich repeat containing 8 family, member A |
chr1_-_168106536 | 3.16 |
ENST00000537209.1
ENST00000361697.2 ENST00000546300.1 ENST00000367835.1 |
GPR161
|
G protein-coupled receptor 161 |
chr4_+_87928413 | 3.13 |
ENST00000544085.1
|
AFF1
|
AF4/FMR2 family, member 1 |
chr22_-_36784035 | 3.07 |
ENST00000216181.5
|
MYH9
|
myosin, heavy chain 9, non-muscle |
chr7_-_107643674 | 3.06 |
ENST00000222399.6
|
LAMB1
|
laminin, beta 1 |
chr18_+_61143994 | 2.90 |
ENST00000382771.4
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
chr10_-_29923893 | 2.81 |
ENST00000355867.4
|
SVIL
|
supervillin |
chr10_-_17659357 | 2.75 |
ENST00000326961.6
ENST00000361271.3 |
PTPLA
|
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
chr2_-_112237835 | 2.75 |
ENST00000442293.1
ENST00000439494.1 |
MIR4435-1HG
|
MIR4435-1 host gene (non-protein coding) |
chr19_+_45971246 | 2.69 |
ENST00000585836.1
ENST00000417353.2 ENST00000353609.3 ENST00000591858.1 ENST00000443841.2 ENST00000590335.1 |
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
chr4_+_87928140 | 2.68 |
ENST00000307808.6
|
AFF1
|
AF4/FMR2 family, member 1 |
chr22_-_36357671 | 2.49 |
ENST00000408983.2
|
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr1_-_229569834 | 2.48 |
ENST00000366684.3
ENST00000366683.2 |
ACTA1
|
actin, alpha 1, skeletal muscle |
chr6_-_88411911 | 2.46 |
ENST00000257787.5
|
AKIRIN2
|
akirin 2 |
chr5_-_176923846 | 2.43 |
ENST00000506537.1
|
PDLIM7
|
PDZ and LIM domain 7 (enigma) |
chr2_+_191792376 | 2.25 |
ENST00000409428.1
ENST00000409215.1 |
GLS
|
glutaminase |
chr2_-_106054952 | 2.24 |
ENST00000336660.5
ENST00000393352.3 ENST00000607522.1 |
FHL2
|
four and a half LIM domains 2 |
chr1_+_16085244 | 2.12 |
ENST00000400773.1
|
FBLIM1
|
filamin binding LIM protein 1 |
chr3_-_99595037 | 2.12 |
ENST00000383694.2
|
FILIP1L
|
filamin A interacting protein 1-like |
chr3_-_123339418 | 2.11 |
ENST00000583087.1
|
MYLK
|
myosin light chain kinase |
chr11_-_65626797 | 2.11 |
ENST00000525451.2
|
CFL1
|
cofilin 1 (non-muscle) |
chr5_-_176923803 | 2.10 |
ENST00000506161.1
|
PDLIM7
|
PDZ and LIM domain 7 (enigma) |
chr2_+_87769459 | 2.10 |
ENST00000414030.1
ENST00000437561.1 |
LINC00152
|
long intergenic non-protein coding RNA 152 |
chr3_-_123339343 | 2.04 |
ENST00000578202.1
|
MYLK
|
myosin light chain kinase |
chr17_-_72358001 | 2.03 |
ENST00000375366.3
|
BTBD17
|
BTB (POZ) domain containing 17 |
chr19_-_17356697 | 2.02 |
ENST00000291442.3
|
NR2F6
|
nuclear receptor subfamily 2, group F, member 6 |
chr17_-_79481666 | 1.99 |
ENST00000575659.1
|
ACTG1
|
actin, gamma 1 |
chr11_-_2162468 | 1.89 |
ENST00000434045.2
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr19_+_1026298 | 1.87 |
ENST00000263097.4
|
CNN2
|
calponin 2 |
chr19_+_1026566 | 1.74 |
ENST00000348419.3
ENST00000565096.2 ENST00000562958.2 ENST00000562075.2 ENST00000607102.1 |
CNN2
|
calponin 2 |
chr17_-_41132410 | 1.72 |
ENST00000409446.3
ENST00000453594.1 ENST00000409399.1 ENST00000421990.2 |
PTGES3L
PTGES3L-AARSD1
|
prostaglandin E synthase 3 (cytosolic)-like PTGES3L-AARSD1 readthrough |
chr2_-_106015491 | 1.69 |
ENST00000408995.1
ENST00000393353.3 ENST00000322142.8 |
FHL2
|
four and a half LIM domains 2 |
chr20_+_35169885 | 1.68 |
ENST00000279022.2
ENST00000346786.2 |
MYL9
|
myosin, light chain 9, regulatory |
chr15_+_33603147 | 1.62 |
ENST00000415757.3
ENST00000389232.4 |
RYR3
|
ryanodine receptor 3 |
chr1_+_11994715 | 1.61 |
ENST00000449038.1
ENST00000376369.3 ENST00000429000.2 ENST00000196061.4 |
PLOD1
|
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 |
chr2_-_106015527 | 1.60 |
ENST00000344213.4
ENST00000358129.4 |
FHL2
|
four and a half LIM domains 2 |
chr9_-_35691017 | 1.58 |
ENST00000378292.3
|
TPM2
|
tropomyosin 2 (beta) |
chr7_-_27183263 | 1.57 |
ENST00000222726.3
|
HOXA5
|
homeobox A5 |
chr8_-_22550815 | 1.56 |
ENST00000317216.2
|
EGR3
|
early growth response 3 |
chr3_-_99594948 | 1.55 |
ENST00000471562.1
ENST00000495625.2 |
FILIP1L
|
filamin A interacting protein 1-like |
chr19_+_52102540 | 1.55 |
ENST00000601315.1
|
AC018755.17
|
AC018755.17 |
chr12_-_11548496 | 1.55 |
ENST00000389362.4
ENST00000565533.1 ENST00000546254.1 |
PRB2
PRB1
|
proline-rich protein BstNI subfamily 2 proline-rich protein BstNI subfamily 1 |
chr15_-_35088340 | 1.54 |
ENST00000290378.4
|
ACTC1
|
actin, alpha, cardiac muscle 1 |
chr15_+_83776324 | 1.54 |
ENST00000379390.6
ENST00000379386.4 ENST00000565774.1 ENST00000565982.1 |
TM6SF1
|
transmembrane 6 superfamily member 1 |
chr11_-_2162162 | 1.50 |
ENST00000381389.1
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr16_-_11375179 | 1.47 |
ENST00000312511.3
|
PRM1
|
protamine 1 |
chr5_-_179050660 | 1.37 |
ENST00000519056.1
ENST00000506721.1 ENST00000503105.1 ENST00000504348.1 ENST00000508103.1 ENST00000510431.1 ENST00000515158.1 ENST00000393432.4 ENST00000442819.2 |
HNRNPH1
|
heterogeneous nuclear ribonucleoprotein H1 (H) |
chr7_-_121944491 | 1.35 |
ENST00000331178.4
ENST00000427185.2 ENST00000442488.2 |
FEZF1
|
FEZ family zinc finger 1 |
chr17_-_4890919 | 1.34 |
ENST00000572543.1
ENST00000381311.5 ENST00000348066.3 ENST00000358183.4 |
CAMTA2
|
calmodulin binding transcription activator 2 |
chr3_-_46904946 | 1.29 |
ENST00000292327.4
|
MYL3
|
myosin, light chain 3, alkali; ventricular, skeletal, slow |
chr3_-_46904918 | 1.26 |
ENST00000395869.1
|
MYL3
|
myosin, light chain 3, alkali; ventricular, skeletal, slow |
chr12_-_50616382 | 1.20 |
ENST00000552783.1
|
LIMA1
|
LIM domain and actin binding 1 |
chr19_-_35166604 | 1.19 |
ENST00000601241.1
|
SCGB2B2
|
secretoglobin, family 2B, member 2 |
chr8_+_125954281 | 1.17 |
ENST00000510897.2
ENST00000533286.1 |
LINC00964
|
long intergenic non-protein coding RNA 964 |
chr1_+_50574585 | 1.17 |
ENST00000371824.1
ENST00000371823.4 |
ELAVL4
|
ELAV like neuron-specific RNA binding protein 4 |
chr7_-_94285472 | 1.16 |
ENST00000437425.2
ENST00000447873.1 ENST00000415788.2 |
SGCE
|
sarcoglycan, epsilon |
chr7_-_94285402 | 1.14 |
ENST00000428696.2
ENST00000445866.2 |
SGCE
|
sarcoglycan, epsilon |
chr6_+_27107053 | 1.12 |
ENST00000354348.2
|
HIST1H4I
|
histone cluster 1, H4i |
chr12_-_50616122 | 1.07 |
ENST00000552823.1
ENST00000552909.1 |
LIMA1
|
LIM domain and actin binding 1 |
chr8_+_97597148 | 1.06 |
ENST00000521590.1
|
SDC2
|
syndecan 2 |
chr2_-_172087824 | 1.06 |
ENST00000521943.1
|
TLK1
|
tousled-like kinase 1 |
chr7_-_94285511 | 1.04 |
ENST00000265735.7
|
SGCE
|
sarcoglycan, epsilon |
chr11_+_86667117 | 1.03 |
ENST00000531827.1
|
RP11-736K20.6
|
RP11-736K20.6 |
chr6_-_123957942 | 1.02 |
ENST00000398178.3
|
TRDN
|
triadin |
chr2_-_209118974 | 1.00 |
ENST00000415913.1
ENST00000415282.1 ENST00000446179.1 |
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble |
chr12_+_62654119 | 0.99 |
ENST00000353364.3
ENST00000549523.1 ENST00000280377.5 |
USP15
|
ubiquitin specific peptidase 15 |
chr5_+_66254698 | 0.96 |
ENST00000405643.1
ENST00000407621.1 ENST00000432426.1 |
MAST4
|
microtubule associated serine/threonine kinase family member 4 |
chr18_-_54318353 | 0.94 |
ENST00000590954.1
ENST00000540155.1 |
TXNL1
|
thioredoxin-like 1 |
chr17_-_4890649 | 0.92 |
ENST00000361571.5
|
CAMTA2
|
calmodulin binding transcription activator 2 |
chr6_-_99797522 | 0.91 |
ENST00000389677.5
|
FAXC
|
failed axon connections homolog (Drosophila) |
chr4_-_10118469 | 0.90 |
ENST00000499869.2
|
WDR1
|
WD repeat domain 1 |
chr11_-_71823266 | 0.88 |
ENST00000538919.1
ENST00000539395.1 ENST00000542531.1 |
ANAPC15
|
anaphase promoting complex subunit 15 |
chr6_-_123958141 | 0.88 |
ENST00000334268.4
|
TRDN
|
triadin |
chr5_+_137774706 | 0.87 |
ENST00000378339.2
ENST00000254901.5 ENST00000506158.1 |
REEP2
|
receptor accessory protein 2 |
chr12_+_62654155 | 0.86 |
ENST00000312635.6
ENST00000393654.3 ENST00000549237.1 |
USP15
|
ubiquitin specific peptidase 15 |
chr5_-_33892046 | 0.85 |
ENST00000352040.3
|
ADAMTS12
|
ADAM metallopeptidase with thrombospondin type 1 motif, 12 |
chr7_+_112120908 | 0.82 |
ENST00000439068.2
ENST00000312849.4 ENST00000429049.1 |
LSMEM1
|
leucine-rich single-pass membrane protein 1 |
chr1_-_11907829 | 0.82 |
ENST00000376480.3
|
NPPA
|
natriuretic peptide A |
chr7_-_44180884 | 0.81 |
ENST00000458240.1
ENST00000223364.3 |
MYL7
|
myosin, light chain 7, regulatory |
chr5_-_142000883 | 0.79 |
ENST00000359370.6
|
FGF1
|
fibroblast growth factor 1 (acidic) |
chr4_-_10118573 | 0.78 |
ENST00000382452.2
ENST00000382451.2 |
WDR1
|
WD repeat domain 1 |
chr7_-_5570229 | 0.76 |
ENST00000331789.5
|
ACTB
|
actin, beta |
chr12_+_54426637 | 0.75 |
ENST00000312492.2
|
HOXC5
|
homeobox C5 |
chr10_+_75757863 | 0.74 |
ENST00000372755.3
ENST00000211998.4 ENST00000417648.2 |
VCL
|
vinculin |
chr7_-_44180673 | 0.68 |
ENST00000457314.1
ENST00000447951.1 ENST00000431007.1 |
MYL7
|
myosin, light chain 7, regulatory |
chr10_+_96162242 | 0.66 |
ENST00000225235.4
|
TBC1D12
|
TBC1 domain family, member 12 |
chr17_+_3379284 | 0.63 |
ENST00000263080.2
|
ASPA
|
aspartoacylase |
chr3_-_190167571 | 0.63 |
ENST00000354905.2
|
TMEM207
|
transmembrane protein 207 |
chr8_-_101965559 | 0.61 |
ENST00000353245.3
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta |
chr5_+_40679584 | 0.61 |
ENST00000302472.3
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4) |
chr4_-_109087872 | 0.58 |
ENST00000510624.1
|
LEF1
|
lymphoid enhancer-binding factor 1 |
chr17_-_55911970 | 0.58 |
ENST00000581805.1
ENST00000580960.1 |
RP11-60A24.3
|
RP11-60A24.3 |
chr6_+_158402860 | 0.57 |
ENST00000367122.2
ENST00000367121.3 ENST00000355585.4 ENST00000367113.4 |
SYNJ2
|
synaptojanin 2 |
chr11_-_71823715 | 0.55 |
ENST00000545944.1
ENST00000502597.2 |
ANAPC15
|
anaphase promoting complex subunit 15 |
chr11_-_71823796 | 0.55 |
ENST00000545680.1
ENST00000543587.1 ENST00000538393.1 ENST00000535234.1 ENST00000227618.4 ENST00000535503.1 |
ANAPC15
|
anaphase promoting complex subunit 15 |
chr8_+_53850991 | 0.52 |
ENST00000331251.3
|
NPBWR1
|
neuropeptides B/W receptor 1 |
chr3_-_185641681 | 0.50 |
ENST00000259043.7
|
TRA2B
|
transformer 2 beta homolog (Drosophila) |
chr19_+_35861831 | 0.50 |
ENST00000454971.1
|
GPR42
|
G protein-coupled receptor 42 (gene/pseudogene) |
chr2_+_219283815 | 0.47 |
ENST00000248444.5
ENST00000454069.1 ENST00000392114.2 |
VIL1
|
villin 1 |
chr19_-_45826125 | 0.47 |
ENST00000221476.3
|
CKM
|
creatine kinase, muscle |
chr19_-_47975417 | 0.47 |
ENST00000236877.6
|
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
chr22_+_38004473 | 0.45 |
ENST00000414350.3
ENST00000343632.4 |
GGA1
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 1 |
chr16_+_86229728 | 0.44 |
ENST00000601250.1
|
LINC01082
|
long intergenic non-protein coding RNA 1082 |
chr17_-_79479789 | 0.42 |
ENST00000571691.1
ENST00000571721.1 ENST00000573283.1 ENST00000575842.1 ENST00000575087.1 ENST00000570382.1 ENST00000331925.2 |
ACTG1
|
actin, gamma 1 |
chr10_+_114043493 | 0.42 |
ENST00000369422.3
|
TECTB
|
tectorin beta |
chr1_+_47881744 | 0.36 |
ENST00000335071.2
|
FOXE3
|
forkhead box E3 |
chrX_-_103499602 | 0.36 |
ENST00000372588.4
|
ESX1
|
ESX homeobox 1 |
chr5_+_92919043 | 0.35 |
ENST00000327111.3
|
NR2F1
|
nuclear receptor subfamily 2, group F, member 1 |
chr11_+_117070037 | 0.34 |
ENST00000392951.4
ENST00000525531.1 ENST00000278968.6 |
TAGLN
|
transgelin |
chr22_+_38004832 | 0.33 |
ENST00000405147.3
ENST00000429218.1 ENST00000325180.8 ENST00000337437.4 |
GGA1
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 1 |
chr17_-_4871085 | 0.30 |
ENST00000575142.1
ENST00000206020.3 |
SPAG7
|
sperm associated antigen 7 |
chr2_-_96811170 | 0.30 |
ENST00000288943.4
|
DUSP2
|
dual specificity phosphatase 2 |
chr8_-_101965146 | 0.28 |
ENST00000395957.2
ENST00000395948.2 ENST00000457309.1 |
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta |
chr3_+_9834227 | 0.27 |
ENST00000287613.7
ENST00000397261.3 |
ARPC4
|
actin related protein 2/3 complex, subunit 4, 20kDa |
chr11_+_34073195 | 0.26 |
ENST00000341394.4
|
CAPRIN1
|
cell cycle associated protein 1 |
chr3_+_9834179 | 0.25 |
ENST00000498623.2
|
ARPC4
|
actin related protein 2/3 complex, subunit 4, 20kDa |
chr15_-_55581954 | 0.24 |
ENST00000336787.1
|
RAB27A
|
RAB27A, member RAS oncogene family |
chr20_-_62258394 | 0.24 |
ENST00000370077.1
|
GMEB2
|
glucocorticoid modulatory element binding protein 2 |
chrX_-_11284095 | 0.23 |
ENST00000303025.6
ENST00000534860.1 |
ARHGAP6
|
Rho GTPase activating protein 6 |
chrX_+_22056165 | 0.23 |
ENST00000535894.1
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked |
chr6_-_159466136 | 0.21 |
ENST00000367066.3
ENST00000326965.6 |
TAGAP
|
T-cell activation RhoGTPase activating protein |
chr16_+_30077055 | 0.20 |
ENST00000564595.2
ENST00000569798.1 |
ALDOA
|
aldolase A, fructose-bisphosphate |
chr9_+_140772226 | 0.18 |
ENST00000277551.2
ENST00000371372.1 ENST00000277549.5 ENST00000371363.1 ENST00000371357.1 ENST00000371355.4 |
CACNA1B
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
chr17_-_41132010 | 0.18 |
ENST00000409103.1
ENST00000360221.4 |
PTGES3L-AARSD1
|
PTGES3L-AARSD1 readthrough |
chr3_+_9834758 | 0.17 |
ENST00000485273.1
ENST00000433034.1 ENST00000397256.1 |
ARPC4
ARPC4-TTLL3
|
actin related protein 2/3 complex, subunit 4, 20kDa ARPC4-TTLL3 readthrough |
chr17_-_27949911 | 0.17 |
ENST00000492276.2
ENST00000345068.5 ENST00000584602.1 |
CORO6
|
coronin 6 |
chr2_-_128432639 | 0.17 |
ENST00000545738.2
ENST00000355119.4 ENST00000409808.2 |
LIMS2
|
LIM and senescent cell antigen-like domains 2 |
chr16_+_30077098 | 0.15 |
ENST00000395240.3
ENST00000566846.1 |
ALDOA
|
aldolase A, fructose-bisphosphate |
chr13_+_27825446 | 0.11 |
ENST00000311549.6
|
RPL21
|
ribosomal protein L21 |
chr1_-_152332480 | 0.10 |
ENST00000388718.5
|
FLG2
|
filaggrin family member 2 |
chr3_+_143690640 | 0.09 |
ENST00000315691.3
|
C3orf58
|
chromosome 3 open reading frame 58 |
chr18_-_3220106 | 0.08 |
ENST00000356443.4
ENST00000400569.3 |
MYOM1
|
myomesin 1 |
chr6_-_105585022 | 0.07 |
ENST00000314641.5
|
BVES
|
blood vessel epicardial substance |
chr18_+_54318616 | 0.06 |
ENST00000254442.3
|
WDR7
|
WD repeat domain 7 |
chr19_+_48958766 | 0.02 |
ENST00000342291.2
|
KCNJ14
|
potassium inwardly-rectifying channel, subfamily J, member 14 |
chr2_-_231989808 | 0.01 |
ENST00000258400.3
|
HTR2B
|
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 8.9 | GO:0050720 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) interleukin-1 beta biosynthetic process(GO:0050720) response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
2.7 | 16.2 | GO:0007296 | vitellogenesis(GO:0007296) |
2.3 | 13.7 | GO:0090131 | mesenchyme migration(GO:0090131) |
1.5 | 22.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.4 | 5.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.1 | 5.5 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
1.0 | 10.7 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.9 | 5.3 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.9 | 3.5 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.8 | 6.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.8 | 5.4 | GO:2000814 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.8 | 3.1 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.7 | 4.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.5 | 1.6 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.5 | 1.6 | GO:0060435 | bronchiole development(GO:0060435) |
0.5 | 1.9 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.5 | 1.8 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.5 | 4.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.5 | 2.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.4 | 3.4 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.4 | 1.7 | GO:0042247 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
0.4 | 3.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.3 | 3.1 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.3 | 1.0 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.3 | 4.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.3 | 3.7 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.3 | 6.4 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.3 | 2.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 | 1.4 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.2 | 0.6 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.2 | 3.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 0.6 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
0.2 | 1.6 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.2 | 1.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.2 | 0.9 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.8 | GO:1902304 | positive regulation of potassium ion export(GO:1902304) |
0.2 | 1.6 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.2 | 2.1 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 1.2 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 2.7 | GO:0051412 | response to corticosterone(GO:0051412) |
0.1 | 0.6 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 2.0 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 1.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.5 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 2.0 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 2.6 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 5.8 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.1 | 2.9 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.1 | 0.9 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 4.5 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.1 | 5.6 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 1.7 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 2.8 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.5 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.2 | GO:1904383 | response to sodium phosphate(GO:1904383) |
0.0 | 3.6 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
0.0 | 0.2 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.0 | 1.5 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.5 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.0 | 0.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 2.3 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 3.7 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.0 | 2.5 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 2.0 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.1 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.0 | 0.6 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 3.7 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.0 | 0.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.0 | 0.7 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.0 | 3.1 | GO:0001649 | osteoblast differentiation(GO:0001649) |
0.0 | 6.5 | GO:0019216 | regulation of lipid metabolic process(GO:0019216) |
0.0 | 0.8 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.5 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 3.2 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 10.7 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
1.8 | 5.3 | GO:0031523 | Myb complex(GO:0031523) |
1.1 | 6.4 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
1.0 | 3.1 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.9 | 7.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.8 | 6.5 | GO:0035976 | AP1 complex(GO:0035976) |
0.7 | 4.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.6 | 3.2 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.6 | 3.1 | GO:0097513 | actomyosin contractile ring(GO:0005826) myosin II filament(GO:0097513) |
0.5 | 4.8 | GO:0032982 | myosin filament(GO:0032982) |
0.4 | 3.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.3 | 6.5 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.3 | 2.8 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.2 | 3.2 | GO:0097433 | dense body(GO:0097433) |
0.2 | 24.1 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 1.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 0.5 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 5.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 16.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 5.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 7.2 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.1 | 0.6 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.7 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 4.8 | GO:0031672 | A band(GO:0031672) |
0.1 | 22.7 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 1.6 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 2.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 4.0 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 1.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 3.4 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.8 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 4.0 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 0.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 1.5 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 3.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 2.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 1.0 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 8.9 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
1.3 | 5.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
1.3 | 22.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.6 | 2.6 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
0.5 | 1.6 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.5 | 2.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.4 | 4.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.4 | 1.6 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.4 | 4.2 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 1.0 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.3 | 5.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.3 | 1.8 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.2 | 3.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 2.0 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 3.1 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 6.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 1.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 10.7 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 2.1 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.6 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
0.1 | 3.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.9 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.1 | 0.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 2.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 23.2 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.5 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.0 | 0.8 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.0 | 2.5 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 2.8 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 5.4 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
0.0 | 0.8 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 3.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.2 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.0 | 1.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.5 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 2.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 2.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 1.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 5.1 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 1.1 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 2.2 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 2.8 | GO:0005516 | calmodulin binding(GO:0005516) |
0.0 | 0.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 22.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.4 | 10.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 23.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 8.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 5.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 3.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 3.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 6.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 4.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 6.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 7.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 1.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 3.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 1.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.9 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 1.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 2.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.8 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 1.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 22.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 4.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 3.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 4.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 0.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 6.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 13.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 3.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 7.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 2.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 12.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 1.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.8 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 0.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 1.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 1.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 1.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 7.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 1.1 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.8 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 2.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |